254 related articles for article (PubMed ID: 32795465)
21. Poorly differentiated chordoma with whole-genome doubling evolving from a SMARCB1-deficient conventional chordoma: A case report.
Curcio C; Cimera R; Aryeequaye R; Rao M; Fabbri N; Zhang Y; Hameed M
Genes Chromosomes Cancer; 2021 Jan; 60(1):43-48. PubMed ID: 32920865
[TBL] [Abstract][Full Text] [Related]
22. Expression of ezrin, MMP-9, and COX-2 in 50 chordoma specimens: a clinical and immunohistochemical analysis.
Froehlich EV; Scheipl S; Lazàry A; Varga PP; Schmid C; Stammberger H; Beham A; Bodo K; Schroettner H; Quehenberger F; Windhager R; Liegl B; Leithner A
Spine (Phila Pa 1976); 2012 Jun; 37(13):E757-67. PubMed ID: 22228328
[TBL] [Abstract][Full Text] [Related]
23. [Chordoma].
George B; Bresson D; Bouazza S; Froelich S; Mandonnet E; Hamdi S; Orabi M; Polivka M; Cazorla A; Adle-Biassette H; Guichard JP; Duet M; Gayat E; Vallée F; Canova CH; Riet F; Bolle S; Calugaru V; Dendale R; Mazeron JJ; Feuvret L; Boissier E; Vignot S; Puget S; Sainte-Rose C; Beccaria K
Neurochirurgie; 2014 Jun; 60(3):63-140. PubMed ID: 24856008
[TBL] [Abstract][Full Text] [Related]
24. What Are the Conditional Survival and Functional Outcomes After Surgical Treatment of 115 Patients With Sacral Chordoma?
Ji T; Guo W; Yang R; Tang X; Wang Y; Huang L
Clin Orthop Relat Res; 2017 Mar; 475(3):620-630. PubMed ID: 26975382
[TBL] [Abstract][Full Text] [Related]
25. Microsatellite instability in sacral chordoma.
Klingler L; Shooks J; Fiedler PN; Marney A; Butler MG; Schwartz HS
J Surg Oncol; 2000 Feb; 73(2):100-3. PubMed ID: 10694646
[TBL] [Abstract][Full Text] [Related]
26. Chordoma: the nonsarcoma primary bone tumor.
Chugh R; Tawbi H; Lucas DR; Biermann JS; Schuetze SM; Baker LH
Oncologist; 2007 Nov; 12(11):1344-50. PubMed ID: 18055855
[TBL] [Abstract][Full Text] [Related]
27. Sacral chordoma with unusual posterior radiographic presentation.
Coombs RJ; Coiner L
Skeletal Radiol; 1996 Oct; 25(7):679-81. PubMed ID: 8915056
[TBL] [Abstract][Full Text] [Related]
28. Chordomas of the Skull Base, Mobile Spine, and Sacrum: An Epidemiologic Investigation of Presentation, Treatment, and Survival.
Zuckerman SL; Bilsky MH; Laufer I
World Neurosurg; 2018 May; 113():e618-e627. PubMed ID: 29486315
[TBL] [Abstract][Full Text] [Related]
29.
Chiang YC; Park IY; Terzo EA; Tripathi DN; Mason FM; Fahey CC; Karki M; Shuster CB; Sohn BH; Chowdhury P; Powell RT; Ohi R; Tsai YS; de Cubas AA; Khan A; Davis IJ; Strahl BD; Parker JS; Dere R; Walker CL; Rathmell WK
Cancer Res; 2018 Jun; 78(12):3135-3146. PubMed ID: 29724720
[TBL] [Abstract][Full Text] [Related]
30. Chordoma: the entity.
Yakkioui Y; van Overbeeke JJ; Santegoeds R; van Engeland M; Temel Y
Biochim Biophys Acta; 2014 Dec; 1846(2):655-69. PubMed ID: 25193090
[TBL] [Abstract][Full Text] [Related]
31. Analysis of prognostic factors for survival in patients with primary spinal chordoma using the SEER Registry from 1973 to 2014.
Pan Y; Lu L; Chen J; Zhong Y; Dai Z
J Orthop Surg Res; 2018 Apr; 13(1):76. PubMed ID: 29625617
[TBL] [Abstract][Full Text] [Related]
32. Surgical Treatment of Sacral Chordoma: En Bloc Resection with Negative Margins is a Determinant of the Long-Term Outcome.
Colangeli S; Muratori F; Bettini L; Frenos F; Totti F; D'Arienzo A; Campo FR; Scoccianti G; Beltrami G; Campanacci DA; Capanna R
Surg Technol Int; 2018 Nov; 33():343-348. PubMed ID: 30204925
[TBL] [Abstract][Full Text] [Related]
33. Low expression of PHLPP1 in sacral chordoma and its association with poor prognosis.
Chen H; Zhang K; Wu G; Song D; Chen K; Yang H
Int J Clin Exp Pathol; 2015; 8(11):14741-8. PubMed ID: 26823799
[TBL] [Abstract][Full Text] [Related]
34. Long-term clinical outcomes following en bloc resections for sacral chordomas and chondrosarcomas: a series of twenty consecutive patients.
Hsieh PC; Xu R; Sciubba DM; McGirt MJ; Nelson C; Witham TF; Wolinksy JP; Gokaslan ZL
Spine (Phila Pa 1976); 2009 Sep; 34(20):2233-9. PubMed ID: 19752710
[TBL] [Abstract][Full Text] [Related]
35. Carbon ions therapy as single treatment in chordoma of the sacrum. Histologic and metabolic outcome studies.
Evangelisti G; Fiore MR; Bandiera S; Barbanti Brodano G; Terzi S; Girolami M; Pipola V; Righi A; Nanni C; Fanti S; Ghermandi R; Molinelli S; Orecchia R; Boriani S; Gasbarrini A
Eur Rev Med Pharmacol Sci; 2019 May; 23(9):4002-4009. PubMed ID: 31115029
[TBL] [Abstract][Full Text] [Related]
36. Chordoma of the skull base: predictors of tumor recurrence.
Pallini R; Maira G; Pierconti F; Falchetti ML; Alvino E; Cimino-Reale G; Fernandez E; D'Ambrosio E; Larocca LM
J Neurosurg; 2003 Apr; 98(4):812-22. PubMed ID: 12691407
[TBL] [Abstract][Full Text] [Related]
37. High expression of survivin in sacral chordoma.
Chen C; Yang HL; Chen KW; Wang GL; Lu J; Yuan Q; Gu YP; Luo ZP
Med Oncol; 2013 Jun; 30(2):529. PubMed ID: 23504337
[TBL] [Abstract][Full Text] [Related]
38. ADAM10 Is a Potential Novel Prognostic Biomarker for Sacral Chordoma.
Ding Y; Bui MM; Wang Q; Sun X; Zhang M; Niu X; Tian W
Ann Clin Lab Sci; 2019 May; 49(3):309-316. PubMed ID: 31308029
[TBL] [Abstract][Full Text] [Related]
39. Dedifferentiated chordoma arising in irradiated sacral chordoma.
Ikeda H; Honjo J; Sakurai H; Mitsuhashi N; Fukuda T; Niibe H
Radiat Med; 1997; 15(2):109-11. PubMed ID: 9192436
[TBL] [Abstract][Full Text] [Related]
40. Characterization of cancer stem-like cells in chordoma.
Aydemir E; Bayrak OF; Sahin F; Atalay B; Kose GT; Ozen M; Sevli S; Dalan AB; Yalvac ME; Dogruluk T; Türe U
J Neurosurg; 2012 Apr; 116(4):810-20. PubMed ID: 22283189
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]